Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.

One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation.

How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane University to train future physicians in this subject matter.

Statins are the cornerstone of lipid lowering drugs.  Listen as Drs. Natarajan, Michos, and Kara discuss the role of statins for cardiovascular disease prevention as well as new incorporation of some non-statin cholesterol-lowering medications in 2018 AHA/ACC Cholesterol Guidelines.

A deep dive discussion between Drs. Pradeep Natarajan, Ron Blankstein and Khurram Nasir in assessment of Coronary artery calcium (CAC) to help guide prognosis and management. In this podcast learn the role of CAC score.

Listen as Drs. Ferguson and Musunuru review history and uses of PCSK9 inhibitors and how these drugs can transform cardiovascular medicine.

Despite medications to reduce risk of heart cardiovascular disease; heart disease is still the number one leading cause of death in the United States as well as around the world.  Listen to Drs. Ferguson and Musunuru as they review new discoveries in cholesterol metabolism and explore why researchers are continuing to study cholesterol metabolism very intensively.

Atherosclerotic Cardiovascular Disease (ASCVD). risk calculator is a tool that enables healthcare providers and patients to estimate ten-year and lifetime risk of ASCVD. Listen as Dr. Virani explores the reasons why should healthcare professionals should perform ASCVD risk assessment and how the ASCVD Risk Calculator can be used.

What is the prevalence of familial hypercholesterolemia? Learn more as Drs. Mehta and Orringer examine the 2018 cholesterol guidelines and how familial hypercholesterolemia and its treatment fall into the new guideline.

Cardiovascular disease is the leading cause of death for women in the US and worldwide. Listen as Drs. Mehta, Braun, and Lundberg discuss the importance of adding women-specific factors in the guideline and focus on many important areas common in women’s health that includes rheumatologic disorders, such as rheumatoid arthritis, systemic lupus erythematosus, but also unique factors to women such as pregnancy complications.